Kristin A. Shimano, Amanda B. Grimes, Shipra Kaicker, Sanjay Shah et al.
Importance: Eltrombopag, a thrombopoietin receptor agonist, is approved by the US Food and Drug Administration for children with chronic immune thrombocytopenia. Efficacy of eltrombopag during the newly diagnosed phase of pediatric immune thrombocytopenia is unknown. Objective: To determine if the p...